USD 0.0
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | -100.0% |
2009 | 18.5 Thousand USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | -100.0% |
2006 | 64.93 Thousand USD | -46.27% |
2005 | 120.86 Thousand USD | 32044.15% |
2004 | 376.00 USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 FY | - USD | -100.0% |
2010 Q1 | - USD | 100.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2009 Q2 | 6000.00 USD | 0.0% |
2009 Q3 | 25 Thousand USD | 316.67% |
2009 FY | 18.5 Thousand USD | 0.0% |
2009 Q4 | -12.5 Thousand USD | -150.0% |
2009 Q1 | - USD | 0.0% |
2008 Q1 | - USD | 100.0% |
2008 FY | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2007 Q2 | 90.85 Thousand USD | 36.22% |
2007 Q4 | -160.83 Thousand USD | -4995.98% |
2007 FY | - USD | -100.0% |
2007 Q1 | 66.69 Thousand USD | 6920.53% |
2007 Q3 | 3285.00 USD | -96.38% |
2006 FY | 64.93 Thousand USD | -46.27% |
2006 Q4 | 950.00 USD | -97.6% |
2006 Q3 | 39.59 Thousand USD | 2318.45% |
2006 Q2 | 1637.00 USD | -92.81% |
2006 Q1 | 22.75 Thousand USD | -78.71% |
2005 Q2 | - USD | 0.0% |
2005 FY | 120.86 Thousand USD | 32044.15% |
2005 Q1 | - USD | 0.0% |
2005 Q4 | 106.9 Thousand USD | 665.71% |
2005 Q3 | 13.96 Thousand USD | 0.0% |
2004 FY | 376.00 USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
American Medical Technologies Inc. | 3.19 Million USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
Ansell Limited | 1.61 Billion USD | 100.0% |
BG Medicine, Inc. | - USD | NaN% |
Biotage AB (publ) | 184.64 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
Psykey, Inc. | 419.29 Thousand USD | 100.0% |
ConvaTec Group Plc | 2.19 Billion USD | 100.0% |
ConvaTec Group Plc | 2.14 Billion USD | 100.0% |
Encision Inc. | 6.58 Million USD | 100.0% |
Golden Valley Development, Inc | - USD | NaN% |
Hear AtLast Holdings, Inc. | - USD | NaN% |
Innovative MedTech Inc. | 1.82 Million USD | 100.0% |
LifePoint, Inc. | -18.5 Thousand USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 772 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 986.22 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 1.08 Million USD | 100.0% |
SmileDirectClub, Inc. | 470.74 Million USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 100.0% |
SheerVision, Inc. | 3.49 Million USD | 100.0% |
United Health Products, Inc. | - USD | NaN% |
Vasamed, Inc. | 1.38 Million USD | 100.0% |
Wearable Health Solutions, Inc. | 745.09 Thousand USD | 100.0% |
Yubo International Biotech Limited | 104.28 Thousand USD | 100.0% |